Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 53, 2950-2953, July 1, 1993]
© 1993 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lin, C.-S.
Right arrow Articles by Kramer, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lin, C.-S.
Right arrow Articles by Kramer, R.

{alpha}6 Integrin Is Up-regulated in Step Increments Accompanying Neoplastic Transformation and Tumorigenic Conversion of Human Fibroblasts1

Ching-Shwun Lin2, Ken Zhang and Randall Kramer

Laboratory of Cancer Cell Biology, Palo Alto Medical Foundation Research Institute, Palo Alto, California 94301 [C-S. L.], and Department of Stomatology and Anatomy, University of California, San Francisco, California 94143 [C-S. L., K. Z., R. K.]

Integrins are a family of transmembrane glycoproteins that serve as cell-cell and cell-substratum adhesion molecules and help regulate cellular differentiation and proliferation. In malignant cells, which exhibit abnormal differentiation and growth properties, the expression of an altered integrin repertoire could therefore be expected. From a tumorigenic human fibrosarcoma cell line we isolated a unique complementary DNA corresponding to the {alpha}6 integrin subunit. Northern blot analysis using this complementary DNA as probe indicated that {alpha}6 integrin mRNA was abundantly expressed in all neoplastically transformed fibroblast cell lines but not in normal diploid fibroblasts. In addition to its potential as a marker for the neoplastic transformation of human fibroblasts, the {alpha}6 integrin mRNA was also found to be consistently expressed at higher levels in tumorigenic fibroblasts than in immortalized but nontumorigenic fibroblasts. This differential expression of {alpha}6 integrin was reflected at the cell surface protein level using cytofluorometric analysis with specific monoclonal antibody. In contrast, the levels of cell surface expression of other integrins were unchanged (such as {alpha}3 and ß1) or down-regulated (such as {alpha}5) when transformed cells were compared with normal fibroblasts. The incremental up-regulation of {alpha}6 integrin was selective and paralleled the progression of normal cells to immortalized cells and finally to tumorigenic cells. This elevated {alpha}6 subunit associated with the ß1 subunit to form a heterodimer receptor for laminin. Since fibrosarcoma cell invasion of basement membrane has been shown to involve {alpha}6ß1 integrin, then the induction or up-regulation of {alpha}6 expression is an important step in tumor progression and evolution to the invasive phenotype in fibrosarcoma.

1 Supported by NIH Grants CA49423 (C-S. L.), CA51884, DE10564 (R. K.), and Chapman Research Fund (C-S. L.).

2 To whom requests for reprints should be addressed.

Received 3/31/93. Accepted 5/18/93.




This article has been cited by other articles:


Home page
Cancer Res.Home page
M. Dimitrijevic-Bussod, V. S. Balzaretti-Maggi, and D. M. Gadbois
Extracellular Matrix and Radiation G1 Cell Cycle Arrest in Human Fibroblasts
Cancer Res., October 1, 1999; 59(19): 4843 - 4847.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
I Ozaki, K Yamamoto, T Mizuta, S Kajihara, N Fukushima, Y Setoguchi, F Morito, and T Sakai
Differential expression of laminin receptors in human hepatocellular carcinoma
Gut, December 1, 1998; 43(6): 837 - 842.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1993 by the American Association for Cancer Research.